Sonja I. Buschow

This study identifies ROPN1 as a target for TCR-engineered T-cells effective against TNBC in preclinical models and demonstrates their safety and efficacy.

This paper improves MHC-I binding peptide prediction generalizability using geometric deep learning, outperforming sequence-based methods without binding affinity data.